Fibromyalgia Syndrome and Chronic Pelvic Pain

N/AEnrolling By InvitationNCT07344675

Sisli Hamidiye Etfal Training and Research Hospital128 enrolled

Overview

This study aimed to compare patients with and without fibromyalgia syndrome in terms of chronic pelvic pain and pelvic floor dysfunction.

The study planned for two patient groups in the Physical Medicine and Rehabilitation outpatient clinic: female patients followed up for fibromyalgia and a control group matched for age and gender without fibromyalgia syndrome. Demographic data, symptom duration, chronic pelvic pain, and pelvic dysfunction symptoms will be assessed in both groups. Pain levels will be measured using the Visual Analog Scale and the McGill Pain Questionnaire Short Form. Additionally, the Fibromyalgia Impact Questionnaire, the Chronic Pelvic Pain Impact Questionnaire, and the Short Form-12 for quality of life assessment will be completed.

Study Type

OBSERVATIONAL

Enrollment

128

Conditions

Fibromyalgia Fibromyalgia Syndrome Pain Chronic Pelvic Pain Chronic Pelvic Pain Syndrome (CPPS)

Eligibility

Sex: FEMALEMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Female participants aged 18 and over * Voluntary participation in the study Exclusion Criteria: * Individuals with cognitive impairment * History of pelvic surgery within the last 3 months * Severe cardiac, renal, liver disease, respiratory or endocrine dysfunction, uncontrolled psychiatric illness * Pregnant or breastfeeding women * Individuals with neuropathy or central nervous system disorders * History of neoplasm in the pelvic region

Locations (1)

Şişli Hamidiye Etfal Training and Research Hospital

Istanbul, Turkey (Türkiye)

Outcomes

Primary Outcomes

Visual Analog Scale

The score is obtained by measuring, with a ruler, the distance in millimeters along the 10-cm line from the "no pain" reference point to the mark indicated by the patient, yielding a total score between 0 and 100, where higher values reflect increased pain severity.

Time frame: Day 1

Short-Form McGill Pain Questionnaire

The Short-Form McGill Pain Questionnaire was developed as a condensed version of the original instrument. Its core section includes 15 pain descriptors, consisting of 11 sensory and 4 affective items, each rated according to intensity on a 4-point scale from 0 (no pain) to 3 (severe pain).

Time frame: Day 1

Pelvic Pain Impact Questionnaire

The self-administered Pelvic Pain Impact Questionnaire assesses the effect of pelvic pain on daily life. It comprises 8 mandatory and 2 optional items, each rated on a 5-point Likert scale, yielding a total score from 0 to 32, with higher scores indicating greater impact on daily functioning.

Time frame: Day 1

Secondary Outcomes

Fibromyalgia Impact Questionnaire

The Fibromyalgia Impact Questionnaire (FIQ) is a self-administered tool consisting of 10 items; the first item includes 11 questions assessing physical functioning, each rated on a 4-point Likert-type scale.

Time frame: Day 1

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.